Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Blood|November 5, 2013
Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoformsTimothy Tidwell, Jeremy Wechsler, Ramesh C Nayak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2011
Combining EGFR and mTOR blockade for the treatment of epithelioid sarcomaXianbiao Xie, Markus P H Ghadimi, Eric D Young, et al.
Physical Therapy in Sport : Official Journal of the Association of Chartered Physiotherapists in Sports Medicine|May 17, 2025
Evaluating the relationship between the landing error scoring system and single leg squat in ROTC cadetsJulie P Burland, Ryan Nguyen, Michael Sarnelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemiasBella S Guerrouahen, Muneyoshi Futami, Christos Vaklavas, et al.
F1000Research|February 2, 2026
Identification of Pathogenic PKHD1 Variants in Infants with Autosomal Recessive Polycystic Kidney Disease from the Dhofar Region, OmanIntisar Al Alawi, Maha Al Awadi, Fatma Al Awaid, et al.
Research Square|June 17, 2024
Comprehensive Analyses of the Effects of the Small-Molecule Inhibitor of the UHM Domain in the Splicing Factor U2AF1 in Leukemia CellsXinrui Yuan, Mona Kazemi Sabzvar, Amol D Patil, et al.
Molecular Cancer Therapeutics|May 7, 2009
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumorChangye Y Zou, Kerrington D Smith, Quan-Sheng Zhu, et al.
Pediatric Nephrology (Berlin, Germany)|May 4, 2023
The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome-a NEPTUNE cohort studySangeeta Hingorani, Keisha L Gibson, Yuping Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2011
Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumorsKeila E Torres, Quan-Sheng Zhu, Katelynn Bill, et al.
Cancers|March 11, 2020
mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage ImpairmentAntonio Vella, Elisabetta D'Aversa, Martina Api, et al.
Pageof 11